Bringing ayurvedic treatment to mainstream

Over the past 3 months, Kapiva Ayurveda has got in strategic investors, diluting almost 10% of the business into equity

Ayurvedic medicines still continue to be viewed as only a niche alternative to mainstream allopathic drugs. Baidyanath scion Ameve Sharma and entrepreneur Shrey Badhani set out to change this perception in 2015 via Kapiva Ayurveda, with a range of wellness products with both FDA (the US drug regulator) and GMP (Good Manufacturing Practice) certification.

“The products stemmed from a need to introduce allopathy-like doses of ayurvedic remedies for the millennial consumer. While both of us grew up on a steady dose of Ayurveda, we felt friends and colleagues in our age group did not trust the products, as they were not